Results 211 to 220 of about 234,277 (395)

Dysphagia assessment in patients with multiple sclerosis – an additional piece to disability burden

Annals of Clinical and Translational Neurology
Objective People with multiple sclerosis (MS) might experience symptoms that are usually underestimated. Dysphagia should be evaluated within the Expanded Disability Status Scale (EDSS), but clinicians often do not assess it properly.
Davide Ranucci, Fabrizia Falco, Valerio Nicolella, Cristina Di Monaco, Laura Migliaccio, Federica Lamagna, Federica Caracciolo, Martina Eliano, Maria Petracca, Marcello Moccia, Vincenzo Brescia Morra, Antonio Carotenuto, Roberta Lanzillo   +12 more
doaj   +1 more source

Dysphagia in Behcet's syndrome [PDF]

, 1971
S Arma, K. S. Habibulla, Jeremy Price, J. Leigh Collis   +3 more
openalex   +1 more source

A case report: Diagnosis and treatment of idiopathic hypertrophic pachymeningitis

Ibrain, Volume 11, Issue 1, Page 112-116, Spring 2025.
We reported a case of idiopathic hypertrophic dura meningitis diagnosed in our hospital. The patient repeatedly suffered from headaches, followed by blurred vision in the right eye. During this period, multiple sclerosis was considered for diagnosis, and it improved after hormone treatment.
Zhong Luo, Piao Cao, Jing‐Qing Xu, Rong Yan, Jian Wang, Tao Liang, Ya Chen, Zu‐Cai Xu   +7 more
wiley   +1 more source

Dysphagia Caused by Hypertrophic Changes in the Cervical Spine

, 1959
Oliver H. Beahrs, Herbert W. Schmidt
openalex   +2 more sources

Progress of non‐motor symptoms in early‐onset Parkinson's disease

Ibrain, EarlyView.
This study reviews the research progress related to non‐motor symptoms (NMS) in patients with early onset Parkinson's disease (EOPD), including neuropsychiatric symptoms, autonomic dysfunction, sleep disorders, and sensory disorders and also summarizes the characteristics of NMS in the genetic form of Parkinson's disease (PD).
Fanshi Zhang, Aidi Luo, Shusheng Liao, Mei Liu, Jun Zhang, Zucai Xu   +5 more
wiley   +1 more source

OBSERVATIONS ON THE EFFECT OF RIBOFLAVIN ON THE ORAL LESION AND DYSPHAGIA, AND OF RIBOFLAVIN AND BREWER'S YEAST ON DARK ADAPTATION IN A CASE OF SO-CALLED PLUMMER-VINSON SYNDROME

, 1945
H. Pollak
openalex   +1 more source

Long‐term risk and characteristics of cerebrovascular events after upper body radiotherapy among childhood cancer survivors in the DCCSS‐LATER cohort

International Journal of Cancer, Volume 156, Issue 10, Page 1858-1872, 15 May 2025.
What's new? Due to the nature of cancer treatments, childhood cancer survivors have an increased risk of serious adverse events later in life. Here, the authors examined the incidence of cerebrovascular events (CVEs) among childhood cancer survivors who had received upper body radiotherapy.
Lisanne C. Verbruggen, Judith L. Kok, Leontien C. M. Kremer, Geert O. Janssens, Paul J. Nederkoorn, Adriaan Penson, A. Birgitta Versluijs, Andrica C. H. de Vries, Ardine M. J. Reedijk, Dorine Bresters, Eelco W. Hoving, Eline van Dulmen‐den Broeder, Jacqueline J. Loonen, Judith de Bont, Joyce Wilbers, Marloes Louwerens, Margriet van der Heiden‐van der Loo, Marry M. van den Heuvel‐Eibrink, Saskia M. F. Pluijm, Sebastian J. C. M. M. Neggers, Wim J. E. Tissing, Yvo B. W. E. M. Roos, Cécile M. Ronckers, Jop C. Teepen, Helena J. H. van der Pal, on behalf of the DCCSS‐LATER consortium, Jaap den Hartogh, Floor van Leeuwen, Irma van Dijk   +28 more
wiley   +1 more source

An unusual dysphagia [PDF]

European Journal of Cardio-Thoracic Surgery, 2010
Fornengo P, Novelli G, BRUNO, Graziella, CAVALLO PERIN, Paolo   +3 more
openaire   +4 more sources

Cardiogenic Dysphagia by Dysphagia Megalatriensis and Aortica [PDF]

Clinical Gastroenterology and Hepatology, 2020
Mohammad F. Madhoun, Hassaan Zia
openaire   +2 more sources

Considerations to forgo systemic treatment in patients with advanced esophageal or gastric cancer: A real‐world evidence study

International Journal of Cancer, Volume 156, Issue 10, Page 1950-1960, 15 May 2025.
What's new? Most patients with advanced esophageal or gastric cancer do not start palliative systemic treatment. The considerations and rationale in forgoing systemic treatment remain unclear. This nationwide study of patients diagnosed with advanced esophageal or gastric cancer between 2015 and 2021 indicates that the main reason for not starting ...
Ellis Slotman, Marieke Pape, Hanneke W. M. van Laarhoven, Roos E. Pouw, Yvette M. van der Linden, Rob H. A. Verhoeven, Sabine Siesling, Heidi P. Fransen, Natasja J. H. Raijmakers   +8 more
wiley   +1 more source